Back
NeoGenomics Vs. Panbela Therapeutics Industry Stock Comparison
Sell
48
NEO
NeoGenomics
Last Price:
13.94
Seasonality Move:
3.51%
Sell
24
PBLA
Panbela Therapeutics
Last Price:
0.43
Seasonality Move:
-3.76%
Sell
48
NeoGenomics (NEO)
is a Sell
Is NeoGenomics a Buy, Sell or Hold?
- The current NeoGenomics [NEO] share price is $15.22. The Score for NEO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- NEO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
Panbela Therapeutics (PBLA)
is a Sell
Is Panbela Therapeutics a Buy, Sell or Hold?
- The current Panbela Therapeutics [PBLA] share price is $0.44. The Score for PBLA is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- PBLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NEO Stock Price Chart
What is NeoGenomics's stock price today?
-
The NeoGenomics share price today is $15.22
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NEO is experiencing slight buying pressure.
PBLA Stock Price Chart
What is Panbela Therapeutics's stock price today?
-
The Panbela Therapeutics share price today is $0.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBLA is experiencing slight selling pressure.
NEO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.22 | Sell |
Relative Strength Index (14 RSI): | 58.61 | Buy |
Chaikin Money Flow: | 89682 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.85 - 15.13) | Buy |
Bollinger Bands (100): | (14.12 - 17.58) | Sell |
PBLA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.15 | Sell |
Relative Strength Index (14 RSI): | 34.57 | Sell |
Chaikin Money Flow: | -15255 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.45 - 0.61) | Sell |
Bollinger Bands (100): | (-1.7 - 11.88) | Sell |
NEO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.02 | Buy |
20-day SMA: | 14.3 | Buy |
50-day SMA: | 15.03 | Buy |
200-day SMA: | 15.4 | Sell |
8-day EMA: | 14.25 | Buy |
20-day EMA: | 14.34 | Buy |
50-day EMA: | 14.83 | Buy |
200-day EMA: | 15.37 | Sell |
PBLA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.44 | Sell |
20-day SMA: | 0.5 | Sell |
50-day SMA: | 0.73 | Sell |
200-day SMA: | 14.89 | Sell |
8-day EMA: | 0.45 | Sell |
20-day EMA: | 0.52 | Sell |
50-day EMA: | 1.61 | Sell |
200-day EMA: | 752.15 | Sell |
NeoGenomics Earnings Growth & NEO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.12 per share.
Panbela Therapeutics Earnings Growth & PBLA Earnings Dates
- Analysts estimate an earnings increase this quarter of $39.91 per share, a decrease next quarter of $0.00 per share, an increase this year of $2,223.30 per share, and a decrease next year of $0.36 per share.
NeoGenomics Technical Analysis
Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Panbela Therapeutics Technical Analysis
Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |